"Local, nonprofit, community blood center."

During the past decade, Bloodworks Northwest conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bloodworks Northwest" are "Healthy" (2 trials). Many other conditions were trialed in "Bloodworks Northwest" in a lesser frequency.

Most popular intervention types in "Bloodworks Northwest" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alinity s Anti-HBc Assay" (1 trials), "Alinity s Anti-HCV Assay" (1 trials), "Alinity s Anti-HCV II" (1 trials), "Alinity s Chagas Assay" (1 trials) and "Alinity s HBsAg and Alinity s HBsAg Confirmatory Assay" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bloodworks Northwest" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Bloodworks Northwest". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Bloodworks Northwest, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bloodworks Northwest, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".